ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants, including the Omicron variant. We are pleased to report that an independent evaluation conducted by the National Institutes of Health’s (NIH) RADx program has indicated that... AACC American Association for Clinical Chemistry July 26th – July 28th 2022 McCormick Convention Center Chicago, Illinois Booth 667 NACDS TSE National Association of Trade Drug Stores August 27th – August 29th 2022 Boston Convention Center Boston, Massachusetts... We at ACON Laboratories, Inc. have been continuously monitoring the emergence of SARS-CoV-2 variants and the Omicron variant is no exception. The Omicron variant is notable for the significant number of mutations in the Spike protein. Those mutations are not relevant... SAN DIEGO, CA., October 4, 2021 – ACON Laboratories, Inc., a leading global medical device manufacturer for 25 years, announced today that its Flowflex™ COVID-19 Antigen Home Test has been authorized for emergency use by the U.S. Food and Drug Administration.The... COVID-19 Rapid Test San Diego, CA, December 17, 2020 — ACON Laboratories, Inc., a leading global medical device manufacturer announced today that its SARS-COV-2 IgG/IgM Rapid Test has been authorized for emergency use by FDA under an EUA for use by authorized... 